CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: ceric oxide
Accession: CHEBI:79089
browse the term
Definition: A metal oxide with formula CeO2. It is used for polishing glass, in coatings for infra-red filters to prevent reflection, and as an oxidant and catalyst in organic synthesis.
Synonyms: exact_synonym: dioxocerium
related_synonym: CeO2; Formula=CeO2; InChI=1S/Ce.2O; InChIKey=CETPSERCERDGAM-UHFFFAOYSA-N; SMILES=O=[Ce]=O; ceria; ceric dioxide; cerium dioxide; cerium(4+) oxide; cerium(IV) oxide; cerium(IV)dioxide
xref: CAS:1306-38-3
xref_mesh: MESH:C030583
xref: PMID:21787599; PMID:24300997; Patent:US2564241; Reaxys:11323272; Reaxys:23048445; Wikipedia:Cerium(IV)_oxide
G
AKT1
AKT serine/threonine kinase 1
decreases expression
EXP
ceric oxide analog results in decreased expression of AKT1 mRNA
CTD
PMID:24821434
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
G
ALB
albumin
decreases expression affects expression increases secretion
ISO EXP
ceric oxide results in decreased expression of ALB protein ceric oxide affects the expression of ALB mRNA ceric oxide results in increased secretion of ALB protein
CTD
PMID:22072870 PMID:23726862 PMID:29463257
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
G
AP3D1
adaptor related protein complex 3 subunit delta 1
decreases expression
EXP
ceric oxide analog results in decreased expression of AP3D1 mRNA
CTD
PMID:24821434
NCBI chr19:2,100,988...2,164,616
Ensembl chr19:2,100,988...2,164,468
G
APAF1
apoptotic peptidase activating factor 1
increases expression
EXP
ceric oxide results in increased expression of APAF1 protein
CTD
PMID:24987704
NCBI chr12:98,645,290...98,735,433
Ensembl chr12:98,645,290...98,735,433
G
APOBEC3F
apolipoprotein B mRNA editing enzyme catalytic subunit 3F
decreases expression
EXP
ceric oxide analog results in decreased expression of APOBEC3F mRNA
CTD
PMID:24821434
NCBI chr22:39,040,864...39,055,972
Ensembl chr22:39,040,604...39,055,972
G
BAX
BCL2 associated X, apoptosis regulator
increases expression
EXP
ceric oxide results in increased expression of BAX protein
CTD
PMID:24987704
NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
G
BCL2
BCL2 apoptosis regulator
decreases expression
EXP
ceric oxide results in decreased expression of BCL2 protein
CTD
PMID:24987704
NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
G
BIRC5
baculoviral IAP repeat containing 5
increases expression
ISO
ceric oxide results in increased expression of BIRC5 mRNA
CTD
PMID:29463257
NCBI chr17:78,214,253...78,225,635
Ensembl chr17:78,214,186...78,225,636
G
BRCA1
BRCA1 DNA repair associated
decreases expression
ISO
ceric oxide results in decreased expression of BRCA1 mRNA
CTD
PMID:29463257
NCBI chr17:43,044,295...43,170,327
Ensembl chr17:43,044,295...43,170,245
G
CASP3
caspase 3
increases cleavage increases expression
EXP
ceric oxide results in increased cleavage of CASP3 protein ceric oxide results in increased expression of CASP3 protein
CTD
PMID:24987704 PMID:26028148
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CASP7
caspase 7
affects expression
EXP
ceric oxide analog affects the expression of CASP7 mRNA
CTD
PMID:22960666
NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
G
CASP9
caspase 9
increases expression
EXP
ceric oxide results in increased expression of CASP9 protein
CTD
PMID:24987704
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
G
CAT
catalase
decreases activity affects expression multiple interactions
EXP ISO
ceric oxide results in decreased activity of CAT protein ceric oxide affects the expression of CAT protein Acetylcysteine inhibits the reaction [ceric oxide results in decreased activity of CAT protein]
CTD
PMID:20457660 PMID:23416263
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CCL11
C-C motif chemokine ligand 11
multiple interactions increases expression
ISO
[Antigens, Dermatophagoides co-treated with ceric oxide] results in decreased expression of CCL11 mRNA; [Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CCL11 protein; ceric oxide promotes the reaction [Antigens, Dermatophagoides results in increased expression of CCL11 mRNA] ceric oxide results in increased expression of CCL11 mRNA
CTD
PMID:29463257 PMID:29792201
NCBI chr17:34,285,742...34,288,334
Ensembl chr17:34,285,742...34,288,334
G
CCL17
C-C motif chemokine ligand 17
multiple interactions increases expression
ISO EXP
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CCL17 mRNA ceric oxide results in increased expression of CCL17 mRNA
CTD
PMID:29463257 PMID:29792201
NCBI chr16:57,396,093...57,416,063
Ensembl chr16:57,404,767...57,416,063
G
CCL2
C-C motif chemokine ligand 2
multiple interactions increases expression increases secretion
EXP ISO
[Antigens, Dermatophagoides co-treated with ceric oxide] results in decreased expression of CCL2 mRNA ceric oxide results in increased expression of CCL2 mRNA ceric oxide results in increased secretion of CCL2 protein
CTD
PMID:29463257 PMID:29792201
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCL20
C-C motif chemokine ligand 20
multiple interactions affects expression
ISO
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CCL20 mRNA ceric oxide affects the expression of CCL20 mRNA
CTD
PMID:29463257 PMID:29792201
NCBI chr 2:227,813,842...227,817,556
Ensembl chr 2:227,805,739...227,817,564
G
CCL22
C-C motif chemokine ligand 22
increases expression
ISO
ceric oxide results in increased expression of CCL22 mRNA
CTD
PMID:29463257
NCBI chr16:57,357,909...57,366,189
Ensembl chr16:57,358,783...57,366,189
G
CCL24
C-C motif chemokine ligand 24
increases expression
ISO
ceric oxide results in increased expression of CCL24 mRNA
CTD
PMID:29463257
NCBI chr 7:75,810,825...75,823,372
Ensembl chr 7:75,810,825...75,823,356
G
CCL26
C-C motif chemokine ligand 26
multiple interactions
EXP
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CCL26 mRNA
CTD
PMID:29792201
NCBI chr 7:75,769,524...75,791,597
Ensembl chr 7:75,769,533...75,789,896
G
CCL3
C-C motif chemokine ligand 3
increases expression
ISO
ceric oxide results in increased expression of CCL3 mRNA
CTD
PMID:29463257
NCBI chr17:36,088,256...36,090,143
Ensembl chr17:36,088,256...36,090,169
G
CCL4
C-C motif chemokine ligand 4
increases expression
ISO
ceric oxide results in increased expression of CCL4 mRNA
CTD
PMID:29463257
NCBI chr17:36,103,827...36,105,614
Ensembl chr17:36,103,827...36,105,621
G
CCL7
C-C motif chemokine ligand 7
increases expression
ISO
ceric oxide results in increased expression of CCL7 mRNA
CTD
PMID:29463257
NCBI chr17:34,270,221...34,272,242
Ensembl chr17:34,270,221...34,272,242
G
CCR2
C-C motif chemokine receptor 2
increases expression
ISO
ceric oxide results in increased expression of CCR2 mRNA
CTD
PMID:29463257
NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
G
CD177
CD177 molecule
multiple interactions
ISO
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CD177 mRNA
CTD
PMID:29792201
NCBI chr19:43,353,686...43,366,081
Ensembl chr19:43,353,686...43,363,172
G
CD40LG
CD40 ligand
decreases expression
ISO
ceric oxide results in decreased expression of CD40LG mRNA
CTD
PMID:29463257
NCBI chr X:136,648,158...136,660,390
Ensembl chr X:136,648,158...136,660,390
G
CD63
CD63 molecule
increases expression
EXP
ceric oxide results in increased expression of CD63 protein
CTD
PMID:23726862
NCBI chr12:55,723,535...55,730,041
Ensembl chr12:55,725,323...55,729,707
G
CEACAM8
CEA cell adhesion molecule 8
increases expression
EXP
ceric oxide results in increased expression of CEACAM8 protein
CTD
PMID:23726862
NCBI chr19:42,580,243...42,594,924
Ensembl chr19:42,580,243...42,595,055
G
CLCA1
chloride channel accessory 1
multiple interactions
EXP ISO
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CLCA1 mRNA [Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CLCA1 mRNA; ceric oxide promotes the reaction [Antigens, Dermatophagoides results in increased expression of CLCA1 protein]
CTD
PMID:29792201
NCBI chr 1:86,468,927...86,500,259
Ensembl chr 1:86,468,368...86,500,259
G
CLEC10A
C-type lectin domain containing 10A
multiple interactions
ISO
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CLEC10A mRNA
CTD
PMID:29792201
NCBI chr17:7,074,537...7,080,251
Ensembl chr17:7,074,537...7,080,307
G
CR1
complement C3b/C4b receptor 1 (Knops blood group)
decreases expression
EXP
ceric oxide results in decreased expression of CR1 protein
CTD
PMID:23726862
NCBI chr 1:207,496,157...207,641,765
Ensembl chr 1:207,496,147...207,641,765
G
CX3CL1
C-X3-C motif chemokine ligand 1
increases expression
ISO
ceric oxide results in increased expression of CX3CL1 mRNA
CTD
PMID:29463257
NCBI chr16:57,372,490...57,385,044
Ensembl chr16:57,372,477...57,385,044
G
CX3CR1
C-X3-C motif chemokine receptor 1
affects expression
ISO
ceric oxide affects the expression of CX3CR1 mRNA
CTD
PMID:29463257
NCBI chr 3:39,263,494...39,292,966
Ensembl chr 3:39,263,495...39,281,735
G
CXCL10
C-X-C motif chemokine ligand 10
multiple interactions
ISO
ceric oxide inhibits the reaction [Antigens, Dermatophagoides results in increased expression of CXCL10 mRNA]
CTD
PMID:29792201
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
G
CXCL12
C-X-C motif chemokine ligand 12
decreases expression
ISO
ceric oxide results in decreased expression of CXCL12 mRNA
CTD
PMID:29463257
NCBI chr10:44,370,165...44,385,097
Ensembl chr10:44,370,165...44,386,493
G
CXCL8
C-X-C motif chemokine ligand 8
increases secretion multiple interactions increases expression
EXP ISO
ceric oxide analog results in increased secretion of CXCL8 protein ceric oxide promotes the reaction [Antigens, Dermatophagoides results in increased expression of CXCL5 mRNA] [Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CXCL8 mRNA ceric oxide analog results in increased expression of CXCL8 mRNA
CTD
PMID:27060086 PMID:29792201
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CXCL9
C-X-C motif chemokine ligand 9
affects expression
ISO
ceric oxide affects the expression of CXCL9 mRNA
CTD
PMID:29463257
NCBI chr 4:76,001,275...76,007,509
Ensembl chr 4:76,001,275...76,007,509
G
CXCR2
C-X-C motif chemokine receptor 2
increases expression
ISO
ceric oxide results in increased expression of CXCR2 mRNA
CTD
PMID:29463257
NCBI chr 2:218,125,294...218,137,251
Ensembl chr 2:218,125,289...218,137,251
G
CXCR3
C-X-C motif chemokine receptor 3
increases expression
ISO
ceric oxide results in increased expression of CXCR3 mRNA
CTD
PMID:29463257
NCBI chr X:71,615,919...71,618,511
Ensembl chr X:71,615,916...71,618,511
G
CXCR5
C-X-C motif chemokine receptor 5
decreases expression
ISO
ceric oxide results in decreased expression of CXCR5 mRNA
CTD
PMID:29463257
NCBI chr11:118,883,892...118,897,787
Ensembl chr11:118,883,892...118,897,787
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
multiple interactions
EXP
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of CYP1A1 mRNA
CTD
PMID:29792201
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
G
CYP1B1
cytochrome P450 family 1 subfamily B member 1
affects expression
ISO
ceric oxide affects the expression of CYP1B1 mRNA
CTD
PMID:29463257
NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
G
DBNL
drebrin like
decreases expression
EXP
ceric oxide analog results in decreased expression of DBNL mRNA
CTD
PMID:24821434
NCBI chr 7:44,044,702...44,069,456
Ensembl chr 7:44,044,640...44,069,456
G
EPX
eosinophil peroxidase
decreases expression
ISO
ceric oxide results in decreased expression of EPX mRNA
CTD
PMID:29463257
NCBI chr17:58,192,726...58,205,174
Ensembl chr17:58,192,726...58,205,174
G
EXO1
exonuclease 1
affects expression
ISO
ceric oxide affects the expression of EXO1 mRNA
CTD
PMID:29463257
NCBI chr 1:241,847,986...241,889,939
Ensembl chr 1:241,847,967...241,895,148
G
FABP4
fatty acid binding protein 4
increases expression
ISO
ceric oxide results in increased expression of FABP4 mRNA
CTD
PMID:29463257
NCBI chr 8:81,478,419...81,483,233
Ensembl chr 8:81,478,419...81,483,236
G
GCLC
glutamate-cysteine ligase catalytic subunit
decreases expression
ISO
ceric oxide results in decreased expression of GCLC mRNA
CTD
PMID:29463257
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
G
GCLM
glutamate-cysteine ligase modifier subunit
decreases expression
ISO
ceric oxide results in decreased expression of GCLM mRNA
CTD
PMID:29463257
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
G
GPX2
glutathione peroxidase 2
decreases expression
ISO
ceric oxide results in decreased expression of GPX2 mRNA
CTD
PMID:29463257
NCBI chr14:64,939,158...64,942,745
Ensembl chr14:64,939,152...64,942,746
G
HBA1
hemoglobin subunit alpha 1
decreases expression
ISO
ceric oxide results in decreased expression of HBA1 mRNA
CTD
PMID:29463257
NCBI chr16:176,680...177,522
Ensembl chr16:176,680...177,522
G
HFE
homeostatic iron regulator
decreases expression
EXP
ceric oxide analog results in decreased expression of HFE mRNA
CTD
PMID:24821434
NCBI chr 6:26,087,429...26,098,343
Ensembl chr 6:26,087,281...26,098,343
G
HLA-A
major histocompatibility complex, class I, A
decreases expression
EXP
ceric oxide analog results in decreased expression of HLA-A mRNA
CTD
PMID:24821434
NCBI chr 6:29,942,532...29,945,870
Ensembl chr 6:29,941,260...29,949,572
G
HLA-DRB3
major histocompatibility complex, class II, DR beta 3
decreases expression
EXP
ceric oxide analog results in decreased expression of HLA-DRB3 mRNA
CTD
PMID:24821434
G
HLA-H
major histocompatibility complex, class I, H (pseudogene)
decreases expression
EXP
ceric oxide analog results in decreased expression of HLA-H mRNA
CTD
PMID:24821434
NCBI chr 6:29,887,573...29,891,079
Ensembl chr 6:29,887,752...29,890,482
G
HMOX1
heme oxygenase 1
affects expression multiple interactions decreases expression increases expression
EXP
ceric oxide analog affects the expression of HMOX1 mRNA ceric oxide inhibits the reaction [potassium bromate results in increased expression of HMOX1 mRNA] ceric oxide results in decreased expression of HMOX1 mRNA ceric oxide results in increased expression of HMOX1 protein
CTD
PMID:19429248 PMID:22960666 PMID:25618551
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
ID2
inhibitor of DNA binding 2
decreases expression
EXP
ceric oxide analog results in decreased expression of ID2 mRNA
CTD
PMID:24821434
NCBI chr 2:8,682,056...8,684,461
Ensembl chr 2:8,678,845...8,684,461
G
IFIT1
interferon induced protein with tetratricopeptide repeats 1
multiple interactions
ISO
ceric oxide inhibits the reaction [Antigens, Dermatophagoides results in increased expression of IFIT1 mRNA]
CTD
PMID:29792201
NCBI chr10:89,392,623...89,406,487
Ensembl chr10:89,392,546...89,406,487
G
IL13
interleukin 13
multiple interactions
ISO
ceric oxide inhibits the reaction [Antigens, Dermatophagoides results in increased expression of IL13 mRNA]
CTD
PMID:29792201
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
G
IL1A
interleukin 1 alpha
increases expression
ISO
ceric oxide results in increased expression of IL1A mRNA
CTD
PMID:29463257
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
G
IL1B
interleukin 1 beta
increases expression
ISO
ceric oxide results in increased expression of IL1B mRNA; ceric oxide results in increased expression of IL1B protein
CTD
PMID:21624445 PMID:29463257
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1RN
interleukin 1 receptor antagonist
increases expression
ISO
ceric oxide results in increased expression of IL1RN mRNA
CTD
PMID:29463257
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
IL2RB
interleukin 2 receptor subunit beta
decreases expression
ISO
ceric oxide results in decreased expression of IL2RB mRNA
CTD
PMID:29463257
NCBI chr22:37,125,838...37,175,118
Ensembl chr22:37,118,666...37,175,118
G
IL2RG
interleukin 2 receptor subunit gamma
increases expression
ISO
ceric oxide results in increased expression of IL2RG mRNA
CTD
PMID:29463257
NCBI chr X:71,107,404...71,111,577
Ensembl chr X:71,107,404...71,112,108
G
IL4
interleukin 4
multiple interactions
ISO
ceric oxide promotes the reaction [Antigens, Dermatophagoides results in increased expression of IL4 mRNA]
CTD
PMID:29792201
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
IL6
interleukin 6
increases expression multiple interactions
ISO EXP
ceric oxide results in increased expression of IL6 protein [Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of IL6 mRNA
CTD
PMID:21624445 PMID:29792201
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
IRF7
interferon regulatory factor 7
multiple interactions
ISO
ceric oxide inhibits the reaction [Antigens, Dermatophagoides results in increased expression of IRF7 mRNA]
CTD
PMID:29792201
NCBI chr11:612,555...615,950
Ensembl chr11:612,553...615,983
G
KIF13B
kinesin family member 13B
increases expression
EXP
ceric oxide analog results in increased expression of KIF13B mRNA
CTD
PMID:24821434
NCBI chr 8:29,067,278...29,263,388
Ensembl chr 8:29,067,278...29,263,124
G
KITLG
KIT ligand
increases expression
EXP
ceric oxide analog results in increased expression of KITLG mRNA
CTD
PMID:24821434
NCBI chr12:88,492,793...88,580,471
Ensembl chr12:88,492,793...88,580,851
G
LIG4
DNA ligase 4
affects expression
ISO
ceric oxide affects the expression of LIG4 mRNA
CTD
PMID:29463257
NCBI chr13:108,207,442...108,218,349
Ensembl chr13:108,207,439...108,218,368
G
LPO
lactoperoxidase
increases expression
ISO
ceric oxide results in increased expression of LPO mRNA; ceric oxide results in increased expression of LPO protein
CTD
PMID:29463257
NCBI chr17:58,238,584...58,268,518
Ensembl chr17:58,218,548...58,268,518
G
MAPK1
mitogen-activated protein kinase 1
increases phosphorylation multiple interactions
EXP
ceric oxide results in increased phosphorylation of MAPK1 protein Acetylcysteine inhibits the reaction [ceric oxide results in increased phosphorylation of MAPK1 protein]
CTD
PMID:23416263
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK3
mitogen-activated protein kinase 3
multiple interactions increases phosphorylation
EXP
Acetylcysteine inhibits the reaction [ceric oxide results in increased phosphorylation of MAPK3 protein]
CTD
PMID:23416263
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MMP12
matrix metallopeptidase 12
multiple interactions increases expression
ISO
ceric oxide promotes the reaction [Antigens, Dermatophagoides results in increased expression of MMP12 mRNA] ceric oxide results in increased expression of MMP12 mRNA; ceric oxide results in increased expression of MMP12 protein
CTD
PMID:29463257 PMID:29792201
NCBI chr11:102,862,736...102,874,982
Ensembl chr11:102,862,736...102,874,982
G
MMP9
matrix metallopeptidase 9
increases activity increases secretion
EXP
ceric oxide results in increased activity of MMP9 protein ceric oxide results in increased secretion of MMP9 protein
CTD
PMID:23726862
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
MPO
myeloperoxidase
increases secretion increases expression
EXP ISO
ceric oxide results in increased secretion of MPO protein ceric oxide results in increased expression of MPO mRNA
CTD
PMID:23726862 PMID:29463257
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
G
MSH5
mutS homolog 5
increases expression
ISO
ceric oxide results in increased expression of MSH5 mRNA
CTD
PMID:29463257
NCBI chr 6:31,740,005...31,762,676
Ensembl chr 6:31,739,677...31,762,676
G
MUC1
mucin 1, cell surface associated
multiple interactions
EXP
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of MUC1 mRNA
CTD
PMID:29792201
NCBI chr 1:155,185,824...155,192,915
Ensembl chr 1:155,185,824...155,192,916
G
MUC5AC
mucin 5AC, oligomeric mucus/gel-forming
multiple interactions
EXP ISO
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of MUC5AC mRNA
CTD
PMID:29792201
NCBI chr11:1,157,953...1,201,138
Ensembl chr11:1,157,953...1,201,138
G
MUTYH
mutY DNA glycosylase
decreases expression
ISO
ceric oxide results in decreased expression of MUTYH mRNA
CTD
PMID:29463257
NCBI chr 1:45,329,242...45,340,440
Ensembl chr 1:45,329,163...45,340,893
G
NCF2
neutrophil cytosolic factor 2
decreases expression increases expression
ISO
ceric oxide results in decreased expression of NCF2 mRNA ceric oxide results in increased expression of NCF2 mRNA
CTD
PMID:29463257
NCBI chr 1:183,555,562...183,601,849
Ensembl chr 1:183,554,461...183,590,905
G
NFE2L2
NFE2 like bZIP transcription factor 2
affects localization
EXP
ceric oxide affects the localization of NFE2L2 protein
CTD
PMID:19429248
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
G
NGB
neuroglobin
decreases expression
ISO
ceric oxide results in decreased expression of NGB mRNA
CTD
PMID:29463257
NCBI chr14:77,265,483...77,271,206
Ensembl chr14:77,265,483...77,271,206
G
NOXO1
NADPH oxidase organizer 1
increases expression
ISO
ceric oxide results in increased expression of NOXO1 mRNA
CTD
PMID:29463257
NCBI chr16:1,978,917...1,981,469
Ensembl chr16:1,978,917...1,984,192
G
NQO1
NAD(P)H quinone dehydrogenase 1
multiple interactions
EXP
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of NQO1 mRNA
CTD
PMID:29792201
NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
G
OPCML
opioid binding protein/cell adhesion molecule like
increases expression
ISO
ceric oxide results in increased expression of OPCML mRNA
CTD
PMID:29463257
NCBI chr11:132,414,981...133,532,501
Ensembl chr11:132,414,977...133,532,501
G
OSM
oncostatin M
affects expression
ISO
ceric oxide affects the expression of OSM mRNA
CTD
PMID:29463257
NCBI chr22:30,262,829...30,266,851
Ensembl chr22:30,262,829...30,266,851
G
PF4
platelet factor 4
increases expression
ISO
ceric oxide results in increased expression of PF4 mRNA
CTD
PMID:29463257
NCBI chr 4:73,980,811...73,982,124
Ensembl chr 4:73,980,811...73,982,027
G
SAA3P
serum amyloid A3, pseudogene
multiple interactions
ISO
ceric oxide promotes the reaction [Antigens, Dermatophagoides results in increased expression of SAA3 mRNA]
CTD
PMID:29792201
NCBI chr11:18,112,472...18,116,132
Ensembl chr11:18,112,472...18,116,132 Ensembl chr11:18,112,472...18,116,132
G
SCD
stearoyl-CoA desaturase
affects expression
ISO
ceric oxide affects the expression of SCD1 mRNA
CTD
PMID:29463257
NCBI chr10:100,347,233...100,364,826
Ensembl chr10:100,347,233...100,364,826
G
SECTM1
secreted and transmembrane 1
decreases expression
EXP
ceric oxide analog results in decreased expression of SECTM1 mRNA
CTD
PMID:24821434
NCBI chr17:82,321,024...82,333,959
Ensembl chr17:82,321,024...82,334,074
G
SLC26A4
solute carrier family 26 member 4
multiple interactions
EXP ISO
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of SLC26A4 mRNA [Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of SLC26A4 mRNA; ceric oxide promotes the reaction [Antigens, Dermatophagoides results in increased expression of SLC26A4 mRNA]
CTD
PMID:29792201
NCBI chr 7:107,660,828...107,717,809
Ensembl chr 7:107,660,828...107,717,809
G
SMUG1
single-strand-selective monofunctional uracil-DNA glycosylase 1
increases expression
ISO
ceric oxide results in increased expression of SMUG1 mRNA
CTD
PMID:29463257
NCBI chr12:54,158,235...54,188,985
Ensembl chr12:54,121,277...54,189,008
G
SOD2
superoxide dismutase 2
multiple interactions increases expression
EXP
ceric oxide inhibits the reaction [potassium bromate results in increased expression of SOD2 mRNA] ceric oxide results in increased expression of SOD2 mRNA
CTD
PMID:25618551
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
G
SPP1
secreted phosphoprotein 1
decreases expression
ISO
ceric oxide results in decreased expression of SPP1 mRNA
CTD
PMID:29463257
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
G
TAFAZZIN
tafazzin, phospholipid-lysophospholipid transacylase
decreases expression
EXP
ceric oxide analog results in decreased expression of TAFAZZIN mRNA
CTD
PMID:24821434
NCBI chr X:154,411,539...154,421,726
Ensembl chr X:154,411,524...154,421,726
G
TIRAP
TIR domain containing adaptor protein
decreases expression
EXP
ceric oxide analog results in decreased expression of TIRAP mRNA
CTD
PMID:24821434
NCBI chr11:126,283,093...126,294,933
Ensembl chr11:126,282,497...126,298,845
G
TLR6
toll like receptor 6
decreases expression
EXP
ceric oxide analog results in decreased expression of TLR6 mRNA
CTD
PMID:24821434
NCBI chr 4:38,822,897...38,868,390
Ensembl chr 4:38,822,897...38,856,817
G
TNF
tumor necrosis factor
increases expression
ISO
ceric oxide results in increased expression of TNF protein
CTD
PMID:21624445 PMID:27693598
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFSF4
TNF superfamily member 4
affects expression
ISO
ceric oxide affects the expression of TNFSF4 mRNA
CTD
PMID:29463257
NCBI chr 1:173,172,870...173,450,733
Ensembl chr 1:173,183,731...173,207,331
G
TOLLIP
toll interacting protein
decreases expression
EXP
ceric oxide analog results in decreased expression of TOLLIP mRNA
CTD
PMID:24821434
NCBI chr11:1,274,371...1,309,632
Ensembl chr11:1,274,371...1,309,654
G
TP53
tumor protein p53
increases phosphorylation
EXP
ceric oxide results in increased phosphorylation of TP53 protein
CTD
PMID:24987704
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
G
TSLP
thymic stromal lymphopoietin
multiple interactions
EXP
[Antigens, Dermatophagoides co-treated with ceric oxide] results in increased expression of TSLP mRNA
CTD
PMID:29792201
NCBI chr 5:111,070,062...111,078,026
Ensembl chr 5:111,070,062...111,078,026
G
TXNIP
thioredoxin interacting protein
decreases expression
ISO
ceric oxide results in decreased expression of TXNIP mRNA
CTD
PMID:29463257
NCBI chr 1:145,992,435...145,996,579
Ensembl chr 1:145,992,435...145,996,579
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all